Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-18 · accession 0001415889-25-008608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-19 | 2025-03-18 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale | $44.45 | -2,415 | 2,426 | -50% | -$107.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-18 | S | D | 2,415 | $44.45 | 2,426 | D | — | — | (F2) The weighted average sale price for the transaction reported was $44.448421, and the range of prices were between $44.21 and $44.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |